Table 3 Clinical baseline characteristics of the patients in the high- and low-risk groups (NKG2D)
Baseline characteristics | High-risk group (n = 26) | Low-risk group (n = 25) | P |
|---|---|---|---|
Sex (male: female) | 22:4 | 20:5 | 0.713 |
Age (years) | 62 (46–77) | 65 (56–71) | 0.884 |
Child–Pugh (5:6) | 22:3 | 23:2 |  > 0.999 |
TBIL (µmol/L) | 18.8 (8.9–48.2) | 16.1 (6.1–26.5) | 0.332 |
AIB (g/L) | 40.6 (34.3–47.6) | 40 (33.6–48.7) | 0.554 |
PLT (× 109/L) | 131 (55–248) | 140 (70–232) | 0.421 |
PTA (%) | 82 (67–94) | 86 (76–104) | 0.317 |
Etiology (HBV) | HBV(100%) | HBV (100%) |  > 0.999 |
Diameter of HCC (mm) | 25.8 (17–36) | 22.5 (9–40) | 0.174 |
AFP (ng/ml) | 798.5 (1.39–17,694) | 67.1 (2.05–818.0) | 0.306 |
BCLC staging | A (100%) | A (100%) |  > 0.999 |
HBV-DNA (copies/ml) | 359.7 (10–8015) | 131.0 (10–2040) | 0.490 |